

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.72677859 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.92148905 |
| 3 | detection of other organism (GO:0098543) | 5.06796641 |
| 4 | respiratory burst (GO:0045730) | 5.02811960 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 4.80541251 |
| 6 | detection of bacterium (GO:0016045) | 4.77987121 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 4.69734915 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.63689559 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.60915215 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.60915215 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.60915215 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.60915215 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.60915215 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.60915215 |
| 15 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.57797359 |
| 16 | positive regulation of mast cell activation (GO:0033005) | 4.42937013 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.42166967 |
| 18 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.41541110 |
| 19 | neutrophil activation (GO:0042119) | 4.40411800 |
| 20 | leukocyte aggregation (GO:0070486) | 4.35416528 |
| 21 | response to interleukin-15 (GO:0070672) | 4.32909697 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.30954834 |
| 23 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.30106234 |
| 24 | response to peptidoglycan (GO:0032494) | 4.28648763 |
| 25 | cellular extravasation (GO:0045123) | 4.25423103 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.19578292 |
| 27 | granulocyte activation (GO:0036230) | 4.19126825 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10351371 |
| 29 | mast cell activation (GO:0045576) | 4.08720169 |
| 30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.08161130 |
| 31 | interferon-gamma production (GO:0032609) | 4.07743237 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 4.07179073 |
| 33 | cellular response to interleukin-15 (GO:0071350) | 4.02836269 |
| 34 | myeloid cell activation involved in immune response (GO:0002275) | 3.95154706 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.94178384 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93121219 |
| 37 | neutrophil mediated immunity (GO:0002446) | 3.91696077 |
| 38 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.82743749 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.82368525 |
| 40 | * T cell migration (GO:0072678) | 3.81209361 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.79697378 |
| 42 | actin nucleation (GO:0045010) | 3.77427670 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.72585295 |
| 44 | lipoxygenase pathway (GO:0019372) | 3.67540784 |
| 45 | regulation of tolerance induction (GO:0002643) | 3.66555820 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.65326281 |
| 47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.64453661 |
| 48 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.63787969 |
| 49 | regulation of mast cell activation (GO:0033003) | 3.60421767 |
| 50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.58682644 |
| 51 | reactive oxygen species biosynthetic process (GO:1903409) | 3.57512950 |
| 52 | T cell selection (GO:0045058) | 3.57223335 |
| 53 | positive regulation of mast cell degranulation (GO:0043306) | 3.55691907 |
| 54 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.55691907 |
| 55 | superoxide anion generation (GO:0042554) | 3.55362465 |
| 56 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.55280610 |
| 57 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.55280610 |
| 58 | cellular response to zinc ion (GO:0071294) | 3.54973520 |
| 59 | B cell mediated immunity (GO:0019724) | 3.54426486 |
| 60 | leukocyte mediated cytotoxicity (GO:0001909) | 3.54110004 |
| 61 | positive regulation of interferon-alpha production (GO:0032727) | 3.51881747 |
| 62 | response to muramyl dipeptide (GO:0032495) | 3.47893800 |
| 63 | positive T cell selection (GO:0043368) | 3.47872599 |
| 64 | activated T cell proliferation (GO:0050798) | 3.46815214 |
| 65 | negative regulation of cell killing (GO:0031342) | 3.46657984 |
| 66 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.46657984 |
| 67 | pinocytosis (GO:0006907) | 3.46219067 |
| 68 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.43242425 |
| 69 | myeloid dendritic cell activation (GO:0001773) | 3.43105775 |
| 70 | response to host (GO:0075136) | 3.42030528 |
| 71 | response to host defenses (GO:0052200) | 3.42030528 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.42030528 |
| 73 | * dendritic cell chemotaxis (GO:0002407) | 3.41693845 |
| 74 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40938041 |
| 75 | negative regulation of phagocytosis (GO:0050765) | 3.40459425 |
| 76 | regulation of interferon-alpha production (GO:0032647) | 3.37106407 |
| 77 | regulation of B cell differentiation (GO:0045577) | 3.34336060 |
| 78 | regulation of mast cell degranulation (GO:0043304) | 3.33168103 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.30057082 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.29972152 |
| 81 | thymic T cell selection (GO:0045061) | 3.29845623 |
| 82 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.29327041 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.25868646 |
| 84 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.24694800 |
| 85 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.23475189 |
| 86 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.22064220 |
| 87 | positive regulation of tolerance induction (GO:0002645) | 3.20917889 |
| 88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.20106450 |
| 89 | sequestering of actin monomers (GO:0042989) | 3.19652190 |
| 90 | tolerance induction (GO:0002507) | 3.17413040 |
| 91 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.17149642 |
| 92 | positive regulation of B cell differentiation (GO:0045579) | 3.16161526 |
| 93 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.15808189 |
| 94 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.15225800 |
| 95 | regulation of antigen processing and presentation (GO:0002577) | 3.14435139 |
| 96 | myeloid leukocyte mediated immunity (GO:0002444) | 3.14407783 |
| 97 | myeloid leukocyte activation (GO:0002274) | 3.14254083 |
| 98 | mast cell degranulation (GO:0043303) | 3.11093047 |
| 99 | mast cell activation involved in immune response (GO:0002279) | 3.11093047 |
| 100 | positive regulation of macrophage differentiation (GO:0045651) | 3.10119693 |
| 101 | type I interferon signaling pathway (GO:0060337) | 3.09661656 |
| 102 | cellular response to type I interferon (GO:0071357) | 3.09661656 |
| 103 | myeloid dendritic cell differentiation (GO:0043011) | 3.09343455 |
| 104 | leukocyte degranulation (GO:0043299) | 3.09135809 |
| 105 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.08873199 |
| 106 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.08873199 |
| 107 | response to type I interferon (GO:0034340) | 3.06813464 |
| 108 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.06005742 |
| 109 | B cell receptor signaling pathway (GO:0050853) | 3.04697818 |
| 110 | response to host immune response (GO:0052572) | 3.04288427 |
| 111 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.04288427 |
| 112 | regulation of regulatory T cell differentiation (GO:0045589) | 3.04146223 |
| 113 | * regulation of alpha-beta T cell proliferation (GO:0046640) | 3.03919735 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.01865590 |
| 115 | regulation of hypersensitivity (GO:0002883) | 3.01140551 |
| 116 | leukocyte cell-cell adhesion (GO:0007159) | 3.00891961 |
| 117 | positive regulation of granulocyte differentiation (GO:0030854) | 3.00418805 |
| 118 | * cellular defense response (GO:0006968) | 2.99960484 |
| 119 | microglial cell activation (GO:0001774) | 2.99711286 |
| 120 | defense response to protozoan (GO:0042832) | 2.98600833 |
| 121 | * regulation of leukocyte degranulation (GO:0043300) | 2.97512593 |
| 122 | response to protozoan (GO:0001562) | 2.97165849 |
| 123 | positive thymic T cell selection (GO:0045059) | 2.97008784 |
| 124 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.96911608 |
| 125 | negative regulation of interleukin-12 production (GO:0032695) | 2.96716980 |
| 126 | negative regulation of innate immune response (GO:0045824) | 2.96505250 |
| 127 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95594570 |
| 128 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.94936638 |
| 129 | negative thymic T cell selection (GO:0045060) | 2.93266190 |
| 130 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.92542772 |
| 131 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.92095970 |
| 132 | * dendritic cell migration (GO:0036336) | 2.90661195 |
| 133 | regulation of growth of symbiont in host (GO:0044126) | 2.88372465 |
| 134 | negative regulation of growth of symbiont in host (GO:0044130) | 2.88372465 |
| 135 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.88372465 |
| 136 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.88372465 |
| 137 | leukotriene metabolic process (GO:0006691) | 2.87437569 |
| 138 | negative T cell selection (GO:0043383) | 2.86990483 |
| 139 | cellular response to interferon-beta (GO:0035458) | 2.86841907 |
| 140 | macrophage activation (GO:0042116) | 2.86628045 |
| 141 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.84991632 |
| 142 | * positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84467796 |
| 143 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.84386161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.44115716 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.38274990 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.52826344 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.40297236 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.32561949 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.17865712 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.12562009 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.01829780 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.00154254 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58016988 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.44534937 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.41157611 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.14293971 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.08411326 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.94890245 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.90309853 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.63893786 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.58457803 |
| 19 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44598581 |
| 20 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.44195671 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41208951 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39391632 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.38200207 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.35996325 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34629466 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.20548682 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.12748169 |
| 28 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11705769 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06314475 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01870753 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93394572 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.92342379 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88626883 |
| 34 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.88102214 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.87885272 |
| 36 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87513313 |
| 37 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84316967 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.83076666 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.78812560 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75668484 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73070487 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.70230148 |
| 43 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.68363590 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67586386 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62835331 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60185155 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57532200 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.52288662 |
| 49 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51427372 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46993699 |
| 51 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.43544280 |
| 52 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42753601 |
| 53 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41557068 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39148738 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37070614 |
| 56 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.28356992 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24231774 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23340890 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22064026 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20581464 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20329774 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.19131021 |
| 63 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18141173 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15036087 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13347410 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13109513 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12126673 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09694410 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07275261 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06349615 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05044963 |
| 72 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05024615 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04438590 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02726931 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01528279 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99223607 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98682701 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98302721 |
| 79 | MYC_22102868_ChIP-Seq_BL_Human | 0.98093534 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97519047 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 0.95262419 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95260928 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94713805 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94454637 |
| 85 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92718026 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91792463 |
| 87 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90573724 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89090180 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85016549 |
| 90 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84296233 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83063357 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82989839 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80972203 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76619637 |
| 95 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76425792 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75779953 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75447841 |
| 98 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74796584 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74213662 |
| 100 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.73789281 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73674549 |
| 102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72998376 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71728610 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 0.70726091 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.69531346 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66347182 |
| 107 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.64114144 |
| 108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62508866 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.60742372 |
| 110 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.58471761 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.56568774 |
| 112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.55876237 |
| 113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.55367153 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.54633268 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.53834576 |
| 116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.53550409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.15920304 |
| 2 | MP0003436_decreased_susceptibility_to | 3.98702169 |
| 3 | MP0005671_abnormal_response_to | 3.77331490 |
| 4 | * MP0002148_abnormal_hypersensitivity_rea | 3.61921772 |
| 5 | * MP0009785_altered_susceptibility_to | 3.48257265 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.33608223 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.25727539 |
| 8 | * MP0005025_abnormal_response_to | 3.20391199 |
| 9 | MP0006082_CNS_inflammation | 2.95869260 |
| 10 | MP0000685_abnormal_immune_system | 2.87637949 |
| 11 | MP0001790_abnormal_immune_system | 2.85626402 |
| 12 | MP0005387_immune_system_phenotype | 2.85626402 |
| 13 | MP0003303_peritoneal_inflammation | 2.81989530 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.81068892 |
| 15 | MP0003724_increased_susceptibility_to | 2.80760880 |
| 16 | * MP0001800_abnormal_humoral_immune | 2.76535841 |
| 17 | * MP0002723_abnormal_immune_serum | 2.69187640 |
| 18 | * MP0001819_abnormal_immune_cell | 2.60522428 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.60184185 |
| 20 | MP0002405_respiratory_system_inflammati | 2.34302666 |
| 21 | MP0002006_tumorigenesis | 2.29866892 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.23221984 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.22344392 |
| 24 | MP0001853_heart_inflammation | 2.14218522 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.97654709 |
| 26 | * MP0001845_abnormal_inflammatory_respons | 1.96208861 |
| 27 | MP0000858_altered_metastatic_potential | 1.92532617 |
| 28 | * MP0000716_abnormal_immune_system | 1.89497869 |
| 29 | * MP0002398_abnormal_bone_marrow | 1.87947990 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.85816803 |
| 31 | * MP0003448_altered_tumor_morphology | 1.82523860 |
| 32 | * MP0010155_abnormal_intestine_physiology | 1.81403461 |
| 33 | MP0005310_abnormal_salivary_gland | 1.80965424 |
| 34 | MP0004510_myositis | 1.80243919 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.71975867 |
| 36 | MP0009764_decreased_sensitivity_to | 1.70826805 |
| 37 | * MP0000343_altered_response_to | 1.70126736 |
| 38 | * MP0008469_abnormal_protein_level | 1.63325661 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.60395495 |
| 40 | MP0003075_altered_response_to | 1.58395510 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.56961358 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.56236620 |
| 43 | MP0004947_skin_inflammation | 1.55719415 |
| 44 | * MP0002429_abnormal_blood_cell | 1.52616057 |
| 45 | * MP0009333_abnormal_splenocyte_physiolog | 1.50560250 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.50100440 |
| 47 | * MP0000689_abnormal_spleen_morphology | 1.48949672 |
| 48 | * MP0002722_abnormal_immune_system | 1.48029873 |
| 49 | * MP0002998_abnormal_bone_remodeling | 1.38073879 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.33761781 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.26568753 |
| 52 | * MP0004883_abnormal_blood_vessel | 1.22357250 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.18493044 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.18493044 |
| 55 | MP0001851_eye_inflammation | 1.16692095 |
| 56 | * MP0005166_decreased_susceptibility_to | 1.14650045 |
| 57 | MP0003828_pulmonary_edema | 1.13970476 |
| 58 | MP0001873_stomach_inflammation | 1.11366097 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.11143177 |
| 60 | MP0000490_abnormal_crypts_of | 1.08432984 |
| 61 | MP0009763_increased_sensitivity_to | 1.07109961 |
| 62 | MP0010307_abnormal_tumor_latency | 1.06489434 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.05875830 |
| 64 | MP0002933_joint_inflammation | 1.02294940 |
| 65 | MP0000703_abnormal_thymus_morphology | 1.01293755 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 0.99354902 |
| 67 | MP0002009_preneoplasia | 0.98637605 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 0.92516187 |
| 69 | MP0001986_abnormal_taste_sensitivity | 0.90289739 |
| 70 | MP0005076_abnormal_cell_differentiation | 0.89701527 |
| 71 | * MP0000249_abnormal_blood_vessel | 0.87635707 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 0.87350866 |
| 73 | MP0005390_skeleton_phenotype | 0.87195260 |
| 74 | MP0004130_abnormal_muscle_cell | 0.86502282 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.86188063 |
| 76 | * MP0003866_abnormal_defecation | 0.85179553 |
| 77 | MP0006054_spinal_hemorrhage | 0.82945062 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 0.81857007 |
| 79 | MP0009278_abnormal_bone_marrow | 0.79947166 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.79636134 |
| 81 | MP0002132_abnormal_respiratory_system | 0.75161054 |
| 82 | * MP0003690_abnormal_glial_cell | 0.74994917 |
| 83 | * MP0003795_abnormal_bone_structure | 0.72575054 |
| 84 | MP0001663_abnormal_digestive_system | 0.70484774 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.69441217 |
| 86 | MP0008057_abnormal_DNA_replication | 0.65815262 |
| 87 | * MP0005164_abnormal_response_to | 0.65583966 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.65466470 |
| 89 | MP0000920_abnormal_myelination | 0.63528917 |
| 90 | * MP0000604_amyloidosis | 0.63320033 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60094952 |
| 92 | MP0008874_decreased_physiological_sensi | 0.59724113 |
| 93 | MP0004381_abnormal_hair_follicle | 0.59046200 |
| 94 | MP0005388_respiratory_system_phenotype | 0.58852704 |
| 95 | MP0002133_abnormal_respiratory_system | 0.58852704 |
| 96 | MP0008004_abnormal_stomach_pH | 0.58844931 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.58271477 |
| 98 | MP0005451_abnormal_body_composition | 0.56084538 |
| 99 | MP0000371_diluted_coat_color | 0.55265447 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.54355613 |
| 101 | MP0003186_abnormal_redox_activity | 0.53462579 |
| 102 | MP0001958_emphysema | 0.51280660 |
| 103 | * MP0008873_increased_physiological_sensi | 0.50768786 |
| 104 | MP0003045_fibrosis | 0.50443325 |
| 105 | MP0008260_abnormal_autophagy | 0.49643490 |
| 106 | MP0002928_abnormal_bile_duct | 0.48289624 |
| 107 | MP0004484_altered_response_of | 0.47695762 |
| 108 | * MP0002136_abnormal_kidney_physiology | 0.47038423 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.45678786 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.45163563 |
| 111 | MP0001881_abnormal_mammary_gland | 0.43973703 |
| 112 | MP0003252_abnormal_bile_duct | 0.43942630 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.43567450 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.43212839 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.42648895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.63123689 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.07933259 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.88903988 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.64668678 |
| 5 | Myositis (HP:0100614) | 5.31375164 |
| 6 | Orchitis (HP:0100796) | 4.84163037 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.78071092 |
| 8 | Optic neuritis (HP:0100653) | 4.78071092 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.63314373 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.55969177 |
| 11 | Recurrent skin infections (HP:0001581) | 4.51795430 |
| 12 | Obstructive lung disease (HP:0006536) | 4.30739927 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.30739927 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 4.25389284 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.19203868 |
| 16 | Gingivitis (HP:0000230) | 4.08206530 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.96234965 |
| 18 | Spontaneous hematomas (HP:0007420) | 3.88346479 |
| 19 | Meningitis (HP:0001287) | 3.58404314 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.55977575 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50613277 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50613277 |
| 23 | Recurrent viral infections (HP:0004429) | 3.46948504 |
| 24 | Pustule (HP:0200039) | 3.38559835 |
| 25 | Periodontitis (HP:0000704) | 3.36561474 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.36420991 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.25350934 |
| 28 | Vasculitis (HP:0002633) | 3.22981198 |
| 29 | Joint hemorrhage (HP:0005261) | 3.15271383 |
| 30 | Thick nail (HP:0001805) | 3.13936951 |
| 31 | Petechiae (HP:0000967) | 3.10671528 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06308358 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06308358 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06308358 |
| 35 | Keratoconjunctivitis (HP:0001096) | 3.05321670 |
| 36 | Pulmonary infiltrates (HP:0002113) | 3.01258819 |
| 37 | Agnosia (HP:0010524) | 2.95555915 |
| 38 | Hemoptysis (HP:0002105) | 2.95337257 |
| 39 | Prostate neoplasm (HP:0100787) | 2.89172252 |
| 40 | IgM deficiency (HP:0002850) | 2.85682684 |
| 41 | Cellulitis (HP:0100658) | 2.84432455 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.83742713 |
| 43 | Increased cerebral lipofuscin (HP:0011813) | 2.83304566 |
| 44 | Arterial thrombosis (HP:0004420) | 2.82508151 |
| 45 | Disinhibition (HP:0000734) | 2.80520601 |
| 46 | Glomerulonephritis (HP:0000099) | 2.80437501 |
| 47 | Hypochromic anemia (HP:0001931) | 2.79802914 |
| 48 | Stomatitis (HP:0010280) | 2.78946854 |
| 49 | Episodic fever (HP:0001954) | 2.73240603 |
| 50 | Leukocytosis (HP:0001974) | 2.73117504 |
| 51 | Encephalitis (HP:0002383) | 2.71215378 |
| 52 | Amyloidosis (HP:0011034) | 2.70586330 |
| 53 | Hypochromic microcytic anemia (HP:0004840) | 2.70296814 |
| 54 | Abnormality of the prostate (HP:0008775) | 2.70115618 |
| 55 | Axonal loss (HP:0003447) | 2.68225929 |
| 56 | Increased IgM level (HP:0003496) | 2.64984321 |
| 57 | Peritonitis (HP:0002586) | 2.62667018 |
| 58 | Thrombocytosis (HP:0001894) | 2.58911707 |
| 59 | Recurrent pneumonia (HP:0006532) | 2.58202055 |
| 60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.50477927 |
| 61 | Urticaria (HP:0001025) | 2.50383951 |
| 62 | Basal ganglia calcification (HP:0002135) | 2.47185433 |
| 63 | IgG deficiency (HP:0004315) | 2.46163267 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.45581966 |
| 65 | Chronic otitis media (HP:0000389) | 2.44866661 |
| 66 | Abnormality of T cells (HP:0002843) | 2.44304026 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.43538158 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.42786340 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.41500972 |
| 70 | Osteomyelitis (HP:0002754) | 2.41134811 |
| 71 | Epistaxis (HP:0000421) | 2.40779578 |
| 72 | Gingival bleeding (HP:0000225) | 2.40171667 |
| 73 | Eosinophilia (HP:0001880) | 2.40035919 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38648788 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.34214416 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.32798863 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.32690081 |
| 78 | Abnormality of T cell number (HP:0011839) | 2.31898872 |
| 79 | T lymphocytopenia (HP:0005403) | 2.31032108 |
| 80 | Interstitial pulmonary disease (HP:0006530) | 2.31016969 |
| 81 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29559032 |
| 82 | Osteolytic defects of the hand bones (HP:0009699) | 2.29559032 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.28586589 |
| 84 | Chest pain (HP:0100749) | 2.27804986 |
| 85 | Increased IgE level (HP:0003212) | 2.25775571 |
| 86 | Cheilitis (HP:0100825) | 2.21729863 |
| 87 | Gangrene (HP:0100758) | 2.21559603 |
| 88 | Recurrent lower respiratory tract infections (HP:0002783) | 2.20493424 |
| 89 | Hematochezia (HP:0002573) | 2.20094233 |
| 90 | Acute hepatic failure (HP:0006554) | 2.19884162 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.17613481 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 2.15664593 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.14089386 |
| 94 | Abnormality of eosinophils (HP:0001879) | 2.11595267 |
| 95 | Increased serum ferritin (HP:0003281) | 2.10043430 |
| 96 | Granulocytopenia (HP:0001913) | 2.09180202 |
| 97 | Gastrointestinal inflammation (HP:0004386) | 2.08431827 |
| 98 | Abnormality of the endocardium (HP:0004306) | 2.08245018 |
| 99 | Colitis (HP:0002583) | 2.07347950 |
| 100 | Pulmonary embolism (HP:0002204) | 2.06573583 |
| 101 | Joint swelling (HP:0001386) | 2.05758429 |
| 102 | Microcytic anemia (HP:0001935) | 2.04680428 |
| 103 | Recurrent bronchitis (HP:0002837) | 2.03934747 |
| 104 | Abnormality of the peritoneum (HP:0002585) | 2.03287901 |
| 105 | Glomerulopathy (HP:0100820) | 2.03141460 |
| 106 | Stomach cancer (HP:0012126) | 2.02816925 |
| 107 | Autoimmune hemolytic anemia (HP:0001890) | 2.02506798 |
| 108 | Abnormality of complement system (HP:0005339) | 2.02286610 |
| 109 | Skin rash (HP:0000988) | 2.01755666 |
| 110 | Severe combined immunodeficiency (HP:0004430) | 2.01299144 |
| 111 | Anorexia (HP:0002039) | 2.00506051 |
| 112 | Skin ulcer (HP:0200042) | 1.99722245 |
| 113 | Amaurosis fugax (HP:0100576) | 1.99717551 |
| 114 | Acne (HP:0001061) | 1.99712886 |
| 115 | Nasal polyposis (HP:0100582) | 1.99426749 |
| 116 | Vertigo (HP:0002321) | 1.97459947 |
| 117 | Sepsis (HP:0100806) | 1.96991355 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.94977442 |
| 119 | Abnormal platelet volume (HP:0011876) | 1.94346012 |
| 120 | Purpura (HP:0000979) | 1.93454857 |
| 121 | Hemiplegia (HP:0002301) | 1.92936135 |
| 122 | Nephritis (HP:0000123) | 1.91490853 |
| 123 | Verrucae (HP:0200043) | 1.89962059 |
| 124 | Papilloma (HP:0012740) | 1.89962059 |
| 125 | Thyroiditis (HP:0100646) | 1.89002410 |
| 126 | Lymphopenia (HP:0001888) | 1.88756194 |
| 127 | Absent frontal sinuses (HP:0002688) | 1.88479394 |
| 128 | Chronic diarrhea (HP:0002028) | 1.88461683 |
| 129 | Viral hepatitis (HP:0006562) | 1.87664972 |
| 130 | Polyneuropathy (HP:0001271) | 1.87661514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.23736078 |
| 2 | IRAK4 | 4.04044803 |
| 3 | MAP3K14 | 4.00658453 |
| 4 | TXK | 3.25724748 |
| 5 | IRAK3 | 3.24595271 |
| 6 | RIPK4 | 3.19843984 |
| 7 | TYK2 | 3.18526372 |
| 8 | MAP4K1 | 3.00015943 |
| 9 | KIT | 2.43196673 |
| 10 | TAOK3 | 2.30327084 |
| 11 | PRPF4B | 2.28123316 |
| 12 | NEK9 | 2.27267225 |
| 13 | GRK7 | 2.21433896 |
| 14 | JAK3 | 2.18363277 |
| 15 | JAK1 | 2.15386873 |
| 16 | TEC | 2.14296497 |
| 17 | TBK1 | 2.03465351 |
| 18 | PIM2 | 1.97975116 |
| 19 | IKBKE | 1.96101924 |
| 20 | BTK | 1.84768079 |
| 21 | ZAP70 | 1.84733246 |
| 22 | ITK | 1.78214387 |
| 23 | STK10 | 1.72680306 |
| 24 | CSK | 1.67875121 |
| 25 | IKBKB | 1.67048909 |
| 26 | SYK | 1.56635078 |
| 27 | CLK1 | 1.56080474 |
| 28 | MAP3K3 | 1.35122792 |
| 29 | CSF1R | 1.33776927 |
| 30 | LYN | 1.30726227 |
| 31 | LCK | 1.30040972 |
| 32 | PIM1 | 1.27668670 |
| 33 | HCK | 1.22335411 |
| 34 | MAP3K13 | 1.21705171 |
| 35 | ERN1 | 1.21538070 |
| 36 | MAP3K11 | 1.20232514 |
| 37 | TGFBR2 | 1.17397077 |
| 38 | FES | 1.16343393 |
| 39 | TAOK1 | 1.15518651 |
| 40 | MAP3K1 | 1.08502438 |
| 41 | MAP3K12 | 1.05810392 |
| 42 | EPHB1 | 1.04720157 |
| 43 | KSR2 | 1.02830197 |
| 44 | FGFR3 | 1.01765586 |
| 45 | ADRBK2 | 1.00194895 |
| 46 | NME2 | 0.96114425 |
| 47 | BMPR2 | 0.93638547 |
| 48 | TRPM7 | 0.88772071 |
| 49 | MAP2K3 | 0.86799899 |
| 50 | CDK6 | 0.84853477 |
| 51 | CHUK | 0.84644550 |
| 52 | MARK2 | 0.84566335 |
| 53 | MAP3K7 | 0.84307161 |
| 54 | MST4 | 0.82919897 |
| 55 | GRK6 | 0.80058465 |
| 56 | MATK | 0.79272268 |
| 57 | LRRK2 | 0.78682082 |
| 58 | MAP2K2 | 0.76649519 |
| 59 | * JAK2 | 0.76479665 |
| 60 | SIK2 | 0.75935238 |
| 61 | EIF2AK2 | 0.75627519 |
| 62 | MAPK12 | 0.72624848 |
| 63 | SIK3 | 0.71225434 |
| 64 | MAPK7 | 0.70789259 |
| 65 | MARK3 | 0.70513994 |
| 66 | TRIB3 | 0.70071348 |
| 67 | TESK2 | 0.69932410 |
| 68 | YES1 | 0.68980260 |
| 69 | ABL2 | 0.68757349 |
| 70 | RPS6KA4 | 0.68067219 |
| 71 | PRKCQ | 0.67736899 |
| 72 | RPS6KA6 | 0.67599771 |
| 73 | PDPK1 | 0.67584467 |
| 74 | PTK6 | 0.66933417 |
| 75 | MAP3K2 | 0.64730016 |
| 76 | RPS6KC1 | 0.63228622 |
| 77 | RPS6KL1 | 0.63228622 |
| 78 | PRKCD | 0.59750665 |
| 79 | STK4 | 0.56514110 |
| 80 | CDK19 | 0.55909383 |
| 81 | CAMKK2 | 0.55538336 |
| 82 | GRK5 | 0.55534057 |
| 83 | MAPKAPK2 | 0.55257591 |
| 84 | BMX | 0.53351371 |
| 85 | MAP3K6 | 0.52649983 |
| 86 | FGR | 0.51573318 |
| 87 | NUAK1 | 0.50938838 |
| 88 | ABL1 | 0.50538921 |
| 89 | FGFR4 | 0.49286869 |
| 90 | IRAK2 | 0.49157038 |
| 91 | RET | 0.47911133 |
| 92 | MAP3K10 | 0.46628649 |
| 93 | PIK3CG | 0.45953564 |
| 94 | SGK3 | 0.45468102 |
| 95 | IRAK1 | 0.45440554 |
| 96 | CAMKK1 | 0.44768310 |
| 97 | SMG1 | 0.44274731 |
| 98 | STK11 | 0.43700063 |
| 99 | PTK2B | 0.43591762 |
| 100 | RPS6KA2 | 0.43551546 |
| 101 | TNK2 | 0.42909488 |
| 102 | PRKD2 | 0.42830728 |
| 103 | HIPK2 | 0.42337841 |
| 104 | TAOK2 | 0.39869746 |
| 105 | MAP2K4 | 0.39640534 |
| 106 | RAF1 | 0.37963119 |
| 107 | FYN | 0.37462309 |
| 108 | DYRK1B | 0.35753149 |
| 109 | PBK | 0.35464958 |
| 110 | EGFR | 0.34253667 |
| 111 | NLK | 0.33737417 |
| 112 | CDC42BPA | 0.32343829 |
| 113 | DAPK1 | 0.32289944 |
| 114 | MAP3K5 | 0.31744101 |
| 115 | SCYL2 | 0.31455432 |
| 116 | MAPK4 | 0.30643483 |
| 117 | FLT3 | 0.30527894 |
| 118 | ERBB3 | 0.30223621 |
| 119 | STK24 | 0.30047162 |
| 120 | MOS | 0.29715891 |
| 121 | PDK1 | 0.29623316 |
| 122 | MAPK11 | 0.29154173 |
| 123 | PAK4 | 0.28359328 |
| 124 | RIPK1 | 0.28220703 |
| 125 | NEK6 | 0.27328425 |
| 126 | CDK4 | 0.26776409 |
| 127 | ARAF | 0.26123499 |
| 128 | ZAK | 0.22482815 |
| 129 | MAP3K8 | 0.21618696 |
| 130 | KDR | 0.20751554 |
| 131 | IGF1R | 0.18961171 |
| 132 | TTN | 0.18106087 |
| 133 | FRK | 0.17967755 |
| 134 | CDK9 | 0.16654259 |
| 135 | EPHA3 | 0.15622973 |
| 136 | TLK1 | 0.15008269 |
| 137 | MAP2K6 | 0.13638838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.66847167 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.50328462 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.24407516 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58731176 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.56170519 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.55912898 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34324059 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.33452331 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.31020220 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.27286161 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.23882133 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20421613 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.19452553 |
| 14 | Measles_Homo sapiens_hsa05162 | 2.17451933 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 2.12045669 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10907038 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.06394854 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02982581 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.90107001 |
| 20 | Phagosome_Homo sapiens_hsa04145 | 1.89853979 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.88889041 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.87246701 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73453742 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.72060492 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72014084 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.71670002 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.65835422 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63774598 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63250802 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.53719991 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53566205 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52021341 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.49075482 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47785433 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46128586 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44770099 |
| 37 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44199586 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43226214 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38917388 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.37987357 |
| 41 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36688042 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.31506674 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.27521158 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25880591 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23682966 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23375600 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.05492491 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04688994 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.97648853 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86082707 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83111353 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.81687773 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80424961 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79299353 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78712976 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77586399 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74909174 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73193123 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72921945 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69034475 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68132750 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67903714 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66450416 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65513793 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61944211 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61651618 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60996666 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60658793 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59552790 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59544733 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59011564 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56170090 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54561774 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54225628 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53489877 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53156542 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.52760637 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52733417 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52616576 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52071477 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51444951 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51281802 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50301973 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48630010 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47778520 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45365081 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45219817 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44118301 |
| 89 | DNA replication_Homo sapiens_hsa03030 | 0.42333481 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.41830805 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41682929 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41682199 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39857288 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39757384 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.36732082 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36485051 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34175634 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34091748 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33230880 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.32547231 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29598917 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28528484 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28062643 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27527138 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.25173480 |
| 106 | Base excision repair_Homo sapiens_hsa03410 | 0.24760207 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24446858 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23319144 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.23243601 |
| 110 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.21820786 |
| 111 | Homologous recombination_Homo sapiens_hsa03440 | 0.21493587 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20485292 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19818073 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.19272713 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.17760429 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.15819676 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14936137 |
| 118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12946836 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08698438 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.07633390 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.06924215 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.05575000 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.05296470 |

